Pasi Janne
MD, PhD
Professor of Medicine
👥Biography 个人简介
Pasi Janne is a leading investigator of EGFR exon 20 insertion mutations in non-small cell lung cancer. His laboratory and clinical work defined sensitivity patterns of exon 20 variants to novel tyrosine kinase inhibitors. He led pivotal trials establishing mobocertinib and poziotinib clinical activity in this underserved molecular subtype.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Pasi Janne 的研究动态
Follow Pasi Janne's research updates
留下邮箱，当我们发布与 Pasi Janne（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment